Bianca Von Scheidt

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Optimised modular anti-FLAG CAR T cells for solid tumor therapy.

Optimised modular anti-FLAG CAR T cells for solid tumor therapy.

Journal: Clinical & translational immunology

Published: March 26, 2025

Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.

Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.

Journal: Science immunology

Published: January 31, 2025

Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer.

Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer.

Journal: Nature immunology

Published: October 28, 2024

Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.

Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.

Journal: Cancer cell

Published: May 04, 2022

Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.

Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.

Journal: Cancers

Published: November 04, 2021

Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers.

Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers.

Journal: Immunotherapy advances

Published: May 28, 2021

Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.

Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.

Journal: Journal for immunotherapy of cancer

Published: April 20, 2021

A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.

A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 27, 2021

Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.

Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.

Journal: Oncoimmunology

Published: September 17, 2020

Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.

Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.

Journal: Clinical & translational immunology

Published: May 17, 2020

Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.

Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.

Journal: Clinical & translational immunology

Published: April 04, 2020

Enterotoxins can support CAR T cells against solid tumors.

Enterotoxins can support CAR T cells against solid tumors.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 27, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026